Fulvestrant D3
| Product Name | Fulvestrant D3 |
|---|---|
| Alternate Names | Fulvestrant Stable Isotopes, Stable Isotopes of Fulvestrant |
| CAT No. | CS-O-06639 |
| CAS No. | 129453-61-8 (Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 609.8 g/mol |
| Mol. For. | C32H44D3F5O3S |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Fulvestrant |
| Purity | 95% |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | C[C@@]12[C@](CC[C@@H]2O)([H])[C@]3([H])[C@@H](CC4=CC(O)=CC=C4[C@@]3([H])CC1)CC([2H])([2H])CCCCCC([2H])([2H])C[S](CCCC(F)(F)C(F)(F)F)=O |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Fulvestrant D3 is a medication used for the treatment of breast cancer that has progressed after treatment with other anti-estrogen drugs. It is classified as an estrogen receptor antagonist and is administered via injection into the muscle. Fulvestrant D3 works by binding to the estrogen receptor and blocking the effects of estrogen, which is a hormone that can stimulate the growth of breast cancer cells.
Chemically, Fulvestrant D3 is a synthetic derivative of estradiol, which is a type of estrogen. It is labeled as D3 because it contains three deuterium atoms, which are isotopes of hydrogen. This labeling is used for pharmacokinetic studies to track the distribution, metabolism, and elimination of the drug in the body.
The recommended dosage of Fulvestrant D3 is 500 mg injected into the muscle on days 1, 15, and 29, and then once a month thereafter. It is important to note that the injection should be administered by a healthcare professional in a clinical setting.
Like any medication, Fulvestrant D3 may cause side effects, including nausea, vomiting, hot flashes, headache, fatigue, and injection site reactions. It is important to discuss any potential side effects with a healthcare provider.
In conclusion, Fulvestrant D3 is a medication used for the treatment of advanced breast cancer that works by blocking the effects of estrogen. It is administered via injection and contains three deuterium atoms that are used for pharmacokinetic studies. As with any medication, it is important to discuss potential side effects and dosage with a healthcare provider.
Get an Instant Quote
Related Compounds
Fulvestrant D4 | Fulvestrant 9 sulfone D5 | Fulvestrant-D5 | Fulvestrant-9-sulfone-D3 |